Lymphoma & Leukaemia Research Review, Issue 48

In this issue:

Prognostic impact of CR with MRD negativity in R/R AML
Outcomes in AML with FLT3-ITD and IDH mutations
Oral azacitidine maintenance for AML in first remission
Post-transplant ponatinib in Ph-positive ALL
Gemtuzumab ozogamicin + chemo for AML relapsing after allo-HSCT
Post-transplantation cyclophosphamide vs antithymocyte globulin in AML
Allo-HSCT in AML with KPS ≤ 80%
Elderly primary CNS lymphoma treated with R-MPV/cytarabine without WBRT or ASCT
Early response to first-line anti–PD-1 treatment in Hodgkin lymphoma
Subcutaneous rituximab for gastric MALT lymphoma

Please login below to download this issue (PDF)

Subscribe